The Food and Drug Administration is now restricting the use of monoclonal antibody treatments for COVID-19. They say the data shows such treatments are “highly unlikely” to work against the Omicron variant.
FDA Blocks Monoclonal Antibody Treatments
By Jason Perry
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.